Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 11   Home Print this page  Email this page Small font size Default font size Increase font size
 
Lung India RSS FeedCurrent Issue



 ISSN: 0970-2113

 May-June 2016
 Vol: 33
 Issue:  3

 

  From the Editor's desk

Dear Readers,

I hope that you find Lung India useful in boosting your academic pursuits. The editorial team and the leadership of the Indian Chest Society are interested and engaged in improving the journal and its rating. Nothing is possible without your active involvement and inputs. It is a continued request to you all to spare some of your time and contribute to journal, especially with your original research and observations. We also need your help in the peer-review process of the articles submitted to the journal.

This website is a step forward in moving ahead with the time. Henceforth all the issues will be made available online for personal viewing and download. You can also make your submissions online. In due course of time we hope to make the peer-review process online. Though the online .....

read more

 
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal

Pubmed

         
         
Editorial
Tuberculosis therapy in Mumbai: Critical importance of drug-susceptibility testing
Amrita Daftary, Madhukar Pai
India is the ground zero for global tuberculosis (TB) epidemic, and Mumbai is the ground zero for India's epidemic of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB). In thi...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 
Original Article
Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai
Zarir F Udwadia, Jai Bharat Mullerpattan, Kushal D Shah, Camilla S Rodrigues
Background: Treatment of multidrug-resistant tuberculosis (MDR-TB) in the Programmatic Management of Drug-resistant TB program involves a standard regimen with a 6-month intensive phase and an ...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 
Original Article
Relationship of epidermal growth factor receptor activating mutations with histologic subtyping according to International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society 2011 adenocarcinoma classification and their impact on overall survival
Venkata Nagarjuna Maturu, Navneet Singh, Amanjit Bal, Nalini Gupta, Ashim Das, Digambar Behera
Background: There is limited Indian data on epidermal growth factor receptor (EGFR) gene activating mutations (AMs) prevalence and their clinicopathologic associations. The current study aimed ...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]


Read more....